Literature DB >> 30129788

Chinese Society of Gynecological Endocrinology affiliated to the International Society of Gynecological Endocrinology Guideline for Ovarian Tissue Cryopreservation and Transplantation.

Xiangyan Ruan1,2.   

Abstract

In order to promote the standard application of ovarian tissue cryopreservation in China, and to provide effective scientific medical services of fertility preservation for patients, the First Chinese Guideline of Ovarian Tissue Cryopreservation and Transplantation is established according to the agreements between gynecologists, embryologists, oncologists, pediatricians, breast oncologists, hematologists, and experts on Traditional Chinese Medicine (TCM), based on already successful treated cases within Beijing Obstetrics and Gynecology Hospital, Capital Medical University, China, and based on already existing international guidelines on fertility preservation including important publications in this field. The guideline includes selection criteria, evaluation, and indications; SOPs of ovarian tissue removal, transportation, preparation, freezing, and thawing; approaches of ovarian tissue transplantation and follow-up; practical recommendations for ovarian tissue cryopreservation and transplantation including recommendations of the diseases where this method could be available, and treatment of menopausal symptoms during the peri-transplantation period (time between cryopreservation and retransplantation). The aim of this guideline was to be scientific, practical, and operable.

Entities:  

Keywords:  Chinese guideline; Ovarian tissue; cryopreservation and transplantation

Mesh:

Year:  2018        PMID: 30129788     DOI: 10.1080/09513590.2018.1488957

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  1 in total

1.  Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report.

Authors:  Jiaojiao Cheng; Xiangyan Ruan; Juan Du; Fengyu Jin; Yanglu Li; Xiaowei Liu; Husheng Wang; Muqing Gu; Alfred O Mueck
Journal:  J Ovarian Res       Date:  2021-12-12       Impact factor: 4.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.